| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 11/01/2001 | US20010036451 Embolic compositions |
| 11/01/2001 | US20010036439 Diagnosis; radiographic imaging |
| 10/31/2001 | EP1149591A2 Sentinel lymph node detection method and system therefor |
| 10/31/2001 | EP1149111A1 Method and composition for angiogenesis inhibition |
| 10/31/2001 | EP1148878A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors |
| 10/31/2001 | EP0923537B1 Process for the preparation of contrast agents |
| 10/31/2001 | EP0835140B1 Metal complexes of polyaminoacids, and their utilization in diagnostic imaging |
| 10/31/2001 | EP0759785B1 Liposome suspensions as blood pool imaging contrast agents |
| 10/31/2001 | EP0693905B1 Microparticles as ultrasonic contrast media |
| 10/31/2001 | EP0444181B1 C-erbb-2 external domain: gp75 |
| 10/31/2001 | CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same |
| 10/31/2001 | CN1073859C Quick soluble imaging assistant for gastrointestinal ultrasonic diagnosis, and its preparing process |
| 10/30/2001 | US6311086 Overhauser magnetic resonance imaging (ORMI) method comprising ex vivo polarization of a magnetic resonance (MR) imaging agent |
| 10/30/2001 | US6310243 Benzene compounds in which 3 non-adjacent ring atoms are substituted with iodine, 2 of the remaining ring atoms are amide substituted with hydroxy and the other remaining ring atom is a non-amide, hydroxy-substituted nonionic moiety |
| 10/30/2001 | US6309701 Fluorescent nanocrystal-labeled microspheres for fluorescence analyses |
| 10/30/2001 | US6309623 Plurality of perforated microstructures having a mean aerodynamic diameter of less than 5 mum and comprising at least one bioactive agent wherein said suspension medium comprises at least one propellant |
| 10/30/2001 | US6309352 Real time optoacoustic monitoring of changes in tissue properties |
| 10/25/2001 | WO2001079468A2 Drug metabolizing enzymes |
| 10/25/2001 | WO2001079291A2 Secreted proteins |
| 10/25/2001 | WO2001015743A3 Viscosity-standardised compositions which facilitate swallowing in dysphagic subjects |
| 10/25/2001 | US20010034483 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
| 10/25/2001 | US20010034019 Chimeric HCV/GBV-B viruses |
| 10/25/2001 | US20010033832 Methods for treating urinary incontinence in mammals |
| 10/25/2001 | US20010033825 Hydration acrylamide-sodium acrylate copolymer in mineral oil |
| 10/25/2001 | CA2405781A1 Secreted proteins |
| 10/25/2001 | CA2403644A1 Drug metabolizing enzymes |
| 10/24/2001 | EP1148058A1 Porphyrin compound |
| 10/24/2001 | EP1148057A1 Nitroimidazole-supporting porphyrin complex |
| 10/24/2001 | EP1147116A1 Boron steroid mimics and pharmaceutical compositions |
| 10/24/2001 | EP1146913A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 10/24/2001 | EP1146911A2 Novel methods of imaging and treatment with targeted compositions |
| 10/24/2001 | EP1146910A2 Preparations for time-limited marking of biopsy sites |
| 10/24/2001 | EP1146902A1 Treatment of autommune diseases by an agonistic cd40-binding protein |
| 10/24/2001 | EP1146857A2 Materials and methods for making improved micelle compositions |
| 10/24/2001 | CN1319011A Tumor tissue accumulation enhancers for drugs |
| 10/23/2001 | US6306437 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 10/23/2001 | US6306367 Fluorescent conjugate for differentiating between diseased and healthy tissues |
| 10/23/2001 | US6306366 Microparticles that contain gas, galactose and a saturated fatty acid |
| 10/23/2001 | US6306365 Method of identifying molecules that home to a selected organ in vivo |
| 10/23/2001 | US6306094 Instrument having enhanced ultrasound visibility |
| 10/23/2001 | US6305190 Cooling below freezing point; trapping, heating; magnetic resonance imaging; medical diagnosis; hyperpolarization |
| 10/18/2001 | WO2001077174A2 Human transporters and ion channels |
| 10/18/2001 | WO2001077114A1 Inhibitors of prenyl-protein transferase |
| 10/18/2001 | WO2001076644A2 Lipid-based systems for targeting diagnostic agents |
| 10/18/2001 | WO2001076638A2 Compositions for drug delivery |
| 10/18/2001 | WO2001076637A2 Peptide conjugates for drug delivery |
| 10/18/2001 | WO2001076595A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 10/18/2001 | WO2001076556A2 Lipid-based drug delivery systems against parasitic infections |
| 10/18/2001 | WO2001076555A2 Lipid-based drug delivery systems for topical application |
| 10/18/2001 | US20010031731 Free radical scavengers or promoters thereof as therapeutic adjuvants in preterm parturition |
| 10/18/2001 | US20010031243 Novel methods of ultrasound treatment using gas or gaseous precursor-filled compositions |
| 10/18/2001 | US20010031242 Method for magnetic resonance imaging of the lung |
| 10/18/2001 | US20010031035 Functional radiographic imaging methods and agents |
| 10/18/2001 | US20010029739 Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers |
| 10/18/2001 | CA2406352A1 Peptide conjugates for drug delivery |
| 10/18/2001 | CA2406233A1 Compositions for drug delivery |
| 10/18/2001 | CA2405554A1 Intracorporeal medicaments comprising halogenated xanthenes for high energy phototherapeutic treatment of disease |
| 10/18/2001 | CA2404229A1 Human transporters and ion channels |
| 10/17/2001 | EP1144604A1 Cyclic peptide ligands that target urokinase plasminogen activator receptor, their pharmaceutical compositions and use |
| 10/17/2001 | EP1144447A2 Tuberculosis diagnostic test |
| 10/17/2001 | EP0871498B1 Insoluble gas-filled microspheres containing a hydrophobic barrier |
| 10/17/2001 | CN1072966C Prepn. of hollow microcapsules |
| 10/16/2001 | US6303771 Pth |
| 10/16/2001 | US6303102 Visually determining the residence time of a therapeutically effective amount of one or more medicaments or vaccines; marker formulation having a pigment or dye in combination with a suitable carrier |
| 10/16/2001 | US6303101 Bismuth compounds |
| 10/16/2001 | US6303100 Methods for inhibiting the formation of potential endoleaks associated with endovascular repair of abdominal aortic aneurysms |
| 10/16/2001 | CA2178369C Process for the purification and crystallisation of iopamidol |
| 10/11/2001 | WO2001075464A1 A method for magnetic resonance imaging of the lung |
| 10/11/2001 | WO2001075440A2 Schizophrenia related genes |
| 10/11/2001 | WO2001075110A2 Mucin-1 specific binding members and methods of use thereof |
| 10/11/2001 | WO2001074406A2 Dendrimer composition for magnetic resonance analysis |
| 10/11/2001 | WO2001074374A1 Methods for detecting plaques in vivo |
| 10/11/2001 | WO2001074245A1 Method of magnetic resonance imaging |
| 10/11/2001 | WO2001074244A1 Method of magnetic resonance imaging |
| 10/11/2001 | WO2000026248A3 Tuberculosis diagnostic test |
| 10/11/2001 | US20010029617 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 10/11/2001 | US20010029292 Sepsis |
| 10/11/2001 | US20010028877 Chelate compounds; magnetic resonance imaging contrast agent |
| 10/11/2001 | US20010028876 Paramagentic chelate compounds; magnetic resonance imaging contrast agent |
| 10/11/2001 | EP1144447A3 Tuberculosis diagnostic test |
| 10/11/2001 | CA2403998A1 Mucin-1 specific binding members and methods of use thereof |
| 10/11/2001 | CA2401119A1 A method for magnetic resonance imaging of the lung |
| 10/10/2001 | EP1141705A1 FUNCTION-BASED SMALL MOLECULAR WEIGHT COMPOUND SCREENING SYSTEM IN $i(DROSOPHILA MELANOGASTER) |
| 10/10/2001 | EP1141548A1 Peristaltic compressors adapted to non-relaxing compression of polarised gas |
| 10/10/2001 | EP1141009A2 Reagents and methods useful for detecting diseases of the breast |
| 10/10/2001 | EP1140864A2 Vitronectin receptor antagonist pharmaceuticals |
| 10/10/2001 | EP1140829A1 Contrast media for angiography |
| 10/10/2001 | EP1140211A1 Novel ultrasound contrast agents |
| 10/10/2001 | EP1140210A2 Methods and compositions comprising monitoring devices |
| 10/10/2001 | EP1140209A1 Blood pool agents for nuclear magnetic resonance diagnostics |
| 10/10/2001 | EP1140208A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 10/10/2001 | EP1140204A2 Vitronectin receptor antagonist pharmaceuticals |
| 10/10/2001 | EP1140203A2 Vitronectin receptor antagonist pharmaceuticals |
| 10/10/2001 | EP1140170A1 Novel agents and methods for treatment and diagnosis of ocular disorders |
| 10/10/2001 | EP1139886A1 Methods and apparatus for enhancement of transdermal transport |
| 10/10/2001 | EP1139793A2 Inhibitors of the bitter taste response |
| 10/10/2001 | EP1139731A2 Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents |
| 10/10/2001 | CN1072644C 4-fluoroalkyl substituted phenacyl guanidine, its prpearing method, application as medicine or diagnosis agent and medicine containing such compound |
| 10/10/2001 | CN1072521C Contrast medium and use and preparation method thereof |
| 10/09/2001 | US6299860 Method for viewing diseased tissue located within a body cavity |